Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVAX) vs. Competitors

10,192 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NVAXNovavax$8.53$1.41B-18.5320.75%HoldUnlock the NVAX analyst price target with TipRanks PremiumNVAXUnlock the NVAX top-analyst price target with TipRanks Premium
VIRVir Biotechnology$9.96$1.71B-7.9782.08%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumNVAX vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.86$814.71M-5.82-35.52%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumNVAX vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$11.49$3.75B-23.94217.40%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumNVAX vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$2.02$605.26M-3.81-44.81%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumNVAX vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NVAXNovavax8.531.7325.37%
VIRVir Biotechnology9.964.4781.42%
ORICOric Pharmaceuticals7.86-4.20-34.83%
ABCLAbCellera Biologics11.497.89219.17%
SANASana Biotechnology2.02-1.62-44.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts